Sanofi Oncology

Journal Of Clinical Oncology Publishes Phase III ... - Sanofi
PRESS RELEASE 1/3 Journal of Clinical Oncology Publishes Phase III Results of ZALTRAP® (aflibercept) VELOUR Study in Previously Treated Metastatic Colorectal Cancer ... Retrieve Doc

Sanofi Discontinues Clinical Development Of Investigational ...
Sanofi Discontinues Clinical Development of Investigational JAK2 Agent Fedratinib Development and Interim Head of Sanofi Oncology. Sanofi has notified investigators of all ongoing fedratinib trials, as well as health authorities, of its ... Return Document

9 Top Generic Drug Companies - About.com Money
9 Top Generic Drug Companies. Products: Generic acute-care and oncology injectables, intensive-care proprietary pharmaceuticals and biosimilars; Sanofi. Headquarters: France; 2012 sales: €34,947 million overall, €1,844 million in generics; ... Read Article

Licensing Opportunity Oral CXCR4 Antagonists ... - Sanofi
Licensing opportunity Oral CXCR4 Antagonists Potential in oncology, tissue injury/repair, and stroke Mechanism of Action: CXCR4 Antagonist ... Retrieve Content

Reimbursement Representative, And Messages ... - Sanofi Oncology
US.XON.09.04.008 4/09 Printed in U.S.A. ©2009 sanofi-aventis U.S. LLC Hotline hours of operation: Monday to Friday, from 9:00 AM to 8:00 PM ET ... Doc Retrieval

Dynamics In The Pharma And Biotech Industry - YouTube
Elements in the Pharma and Biotech Industry (2010) - $550 Billion (4.7% development) • In 2010, Pfizer, Merck, Novartis, Roche, Sanofi-Aventis 2010 • In 2010, the cardiology helpful region (18.3%) created the most medication deals took after by oncology ... View Video

Biopharmaceutical Fellowship Program - MCPHS University
Presence in Massachusetts includes Genzyme, Sanofi Oncology, Sanofi Renal, Sanofi Biosurgery, Sanofi Pasteur, The Genzyme/Sanofi fellowship program will give the fellows an opportunity to explore the different areas within the pharmaceutical industry ... Access Document

Transforming sanofi-aventis And R&D Portfolio Update
1 Transforming sanofi-aventis and R&D Portfolio Update Paul Chew, Senior VP, U.S. Chief Science/Medical Officer InterContinental Boston Hotel, May 19, 2009 ... Document Viewer

AstraZeneca - Wikipedia, The Free Encyclopedia
AstraZeneca plc [3] is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales (after Pfizer, Sanofi, Novartis, Merck & Co., Roche and ... Read Article

2. Oncology - Strategic Priority for Sanofi . Unmet Medical Need. Impact on Society. Innovative Science. Strong Heritage. Cancer is a leading cause of death globally ... Fetch Full Source

Sanofi Partners With Emcure Pharmaceuticals For Marketing And ...
PRESS RELEASE 1 Sanofi partners with Emcure Pharmaceuticals for marketing and distribution of its oncology portfolio in India Mumbai, August 6th, 2014 - Sanofi in India announced today that it has entered into a marketing ... Access Content

Which Popular Drugs Are Going Off-Patent In 2013-2016?
Which Popular Drugs Are Going Off-Patent in 2013-2016? Good for consumers; bad for industry's bottom line. AstraZeneca's popular anti-cholesterol drug Crestor will lose market exclusivity in 2016. By Kathlyn Stone. Pharma Expert Share Pin Tweet Submit ... Read Article

How To Say Or Pronounce Jevtana - YouTube
Get those medical secrets: http://www.health101.pw/Medical-Secrets.shtml This video shows you how to say or pronounce Jevtana. Audio is from cancer.gov. ... View Video

Data At ASCO Showcase Sanofi’s Commitment To Research And ...
3/3 About Sanofi Oncology Based in Cambridge, Massachusetts, and Vitry, France, Sanofi Oncology is translating science into effective cancer therapeutics to address unmet medical needs for patients with cancer. ... Visit Document

Edited Transcript Of XON Earnings Conference Call Or Presentation 29-Feb-16 10:30pm GMT
Q4 2015 Intrexon Corp Earnings Call ... Read News

Sanofi And Warp Drive Bio To Collaborate On The Development ...
PRESS RELEASE Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms ... Access Content

Updated Articles And Resources - About.com Money
Updated Articles and Resources. Sign Up for Our Free Newsletters Thanks, (docetaxel from Sanofi Oncology). equivalent to Genentech’s Boniva; clopidogrel tablets, equivalent to Sanofi-Aventis’ Plavix; montelukast chewable tablets, granules and tablets, equivalent to Merck’s ... Read Article

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 Fourth Quarter And Full Year Financial ...
THE WOODLANDS, Texas, March 1, 2016 /PRNewswire/ --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months and year ended December 31, 2015 and provided an ... Read News

The Canadian Radiation Oncology Foundation/Sanofi-Aventis ...
1 . The Canadian Radiation Oncology Foundation/Sanofi-Aventis . Research Innovation Award . Announces 2011 Grant Winners . For immediate release . $126,000 to Seven Recipients: Canadian Radiation Oncology Foundation sanofi-aventis Research ... Access Document

Engineering Services For Oncology Center
Genesis performed engineering and design services for a 112,000 s.f. fit-out, including 30,000 s.f. of Chemistry Laboratories, 12,000 s.f. of ... View Doc

PATIENT SUPPORT, PATIENT ADVOCACY, AND ... - Sanofi Oncology
SANOFI-AVENTIS ONCOLOGY PATIENT SUPPORT, PATIENT ADVOCACY, AND REIMBURSEMENT SERVICES Sanofi -aventis is dedicated to providing access to oncology products for patients ... Access Content

Sanofi-aventis U.S. – Independent Medical Education Grants 2nd Quarter 2011 Community Oncology Clinical Debates – Castration-Resistant Prostate Cancer $125,000.00 Alaska Regional Hospital Asthma & Allergy Foundation of America, Alaska ... Retrieve Content

sanofi-aventis APEX Or Mail - McKesson Specialty Health
Contract Onmark, Inc. & sanofi-aventis APEX Declaration Form - ELOXATIN® LETTER OF COMMITMENT The undersigned party (“non-Program Member”) agrees to the terms and conditions set forth below in order to ... Retrieve Content

Sanofi-aventis U.S. is committed to supporting independent medical education activities for patients, consumers and healthcare professionals in our Accreditation Council of Oncology in Europe (ACOE) Multinational Association of Supportive Care in Cancer ... Doc Viewer

Biogen - Wikipedia, The Free Encyclopedia
Biogen is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. ... Read Article